Plaksin; Daniel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Plaksin; Daniel.The latest application filed is for "selective il-6-trans-signalling inhibitor compositions".
Company Profile
10.17.27
- Plaksin; Daniel - St-Prex CH
- Plaksin; Daniel - Rehovot IL
- Plaksin; Daniel - Hoofddorp NL
- Plaksin; Daniel - Revhovot IL
Patent Activity
| Patent | Date |
|---|---|
| Selective Il-6-trans-signalling Inhibitor Compositions App 20220275056 - Cottingham; Ian ; et al. | 2022-09-01 |
| Selective IL-6-trans-signalling inhibitor compositions Grant 11,306,136 - Cottingham , et al. April 19, 2 | 2022-04-19 |
| Pharmaceutical preparation comprising recombinant hCG Grant 11,292,824 - Cottingham , et al. April 5, 2 | 2022-04-05 |
| Pharmaceutical Preparation App 20210332099 - COTTINGHAM; Ian ; et al. | 2021-10-28 |
| Pharmaceutical preparation Grant 10,995,128 - Cottingham , et al. May 4, 2 | 2021-05-04 |
| Fast disintegrating pharmaceutical composition Grant 10,952,959 - Sonavane , et al. March 23, 2 | 2021-03-23 |
| Pharmaceutical Preparation Comprising Recombinant Hcg App 20200247863 - Kind Code | 2020-08-06 |
| Selective Il-6-trans-signalling Inhibitor Compositions App 20200123226 - Cottingham; Ian ; et al. | 2020-04-23 |
| Pharmaceutical preparation comprising recombinant HcG Grant 10,526,390 - Cottingham , et al. J | 2020-01-07 |
| Selective IL-6-trans-signalling inhibitor compositions Grant 10,519,218 - Cottingham , et al. Dec | 2019-12-31 |
| A Fast Disintegrating Pharmaceutical Composition App 20190358156 - SONAVANE; Ganeshchandra ; et al. | 2019-11-28 |
| Optimized nucleic acid sequences coding for the alpha-chain of human chorionic gonadotropin Grant 10,464,984 - Plaksin , et al. No | 2019-11-05 |
| Selective Il-6-trans-signalling Inhibitor Compositions App 20180282396 - Cottingham; Ian ; et al. | 2018-10-04 |
| Pharmaceutical Preparation App 20180079794 - Cottingham; Ian ; et al. | 2018-03-22 |
| Pharmaceutical Preparation Comprising Recombinant HcG App 20180030107 - Cottingham; Ian ; et al. | 2018-02-01 |
| Pharmaceutical preparation Grant 9,771,407 - Cottingham , et al. September 26, 2 | 2017-09-26 |
| Pharmaceutical preparation Grant 9,757,469 - Cottingham , et al. September 12, 2 | 2017-09-12 |
| Pharmaceutical preparation comprising recombinant HcG Grant 9,676,835 - Cottingham , et al. June 13, 2 | 2017-06-13 |
| Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation Grant 9,546,204 - Cottingham , et al. January 17, 2 | 2017-01-17 |
| Pharmaceutical Preparation App 20160347811 - Cottingham; Ian ; et al. | 2016-12-01 |
| Pharmaceutical preparation comprising recombinant hCG Grant 8,975,226 - Cottingham , et al. March 10, 2 | 2015-03-10 |
| Recombinant FSH Including Alpha 2,3- and Alpha 2,6-Sialylation App 20150065695 - Cottingham; Ian ; et al. | 2015-03-05 |
| Recombinant FSH including alpha 2,3- and alpha 2,6-sailylation Grant 8,951,967 - Cottingham , et al. February 10, 2 | 2015-02-10 |
| Pharmaceutical Preparation Comprising Recombinant HcG App 20140249082 - Cottingham; Ian ; et al. | 2014-09-04 |
| Pharmaceutical Preparation App 20140088010 - Cottingham; Ian ; et al. | 2014-03-27 |
| Pharmaceutical Preparation Comprising Recombinant HCG App 20130023476 - Cottingham; Ian ; et al. | 2013-01-24 |
| Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-sailylatio App 20110105398 - Cottingham; Ian ; et al. | 2011-05-05 |
| Antibodies And Uses Thereof App 20090220486 - Plaksin; Daniel ; et al. | 2009-09-03 |
| Specific human antibodies for selective cancer therapy App 20070149768 - Hagay; Yocheved ; et al. | 2007-06-28 |
| Specific human antibodies for selective cancer therapy Grant 7,132,510 - Hagay , et al. November 7, 2 | 2006-11-07 |
| Antibodies and uses thereof App 20050266009 - Plaksin, Daniel ; et al. | 2005-12-01 |
| Specific human antibodies App 20050152906 - Levanon, Avigdor ; et al. | 2005-07-14 |
| Antibodies and uses thereof App 20050069955 - Plaksin, Daniel ; et al. | 2005-03-31 |
| Antibodies and uses thereof App 20040208877 - Levanon, Avigdor ; et al. | 2004-10-21 |
| Specific human antibodies for selective cancer therapy App 20040073011 - Hagay, Yocheved ; et al. | 2004-04-15 |
| Y1-isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof App 20040001822 - Levanon, Avigdor ; et al. | 2004-01-01 |
| Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof App 20040002450 - Lazarovits, Janette ; et al. | 2004-01-01 |
| Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof App 20040001839 - Levanon, Avigdor ; et al. | 2004-01-01 |
| Small functional units of antibody heavy chain variable regions App 20020012909 - Plaksin, Daniel | 2002-01-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 